Clinical Trial: A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Repeat-Dose, Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Study to Determine the Safety and Efficacy of Flurbiprofen 8.75 mg Lozenge Compared to Its Vehicle Control Lozenge in Patient

Brief Summary: The purposes of this study is to demonstrate the analgesic efficacy of flurbiprofen 8.75 mg lozenge compared to its vehicle lozenge and to demonstrate the safety of the flurbiprofen lozenge throughout the course of treating sore throat due to acute pharyngitis.

Detailed Summary:
Sponsor: Reckitt Benckiser LLC

Current Primary Outcome: The primary Outcome Measure in this trial will be efficacy for Sore Throat Pain during the first 24 hours. [ Time Frame: 24 hours ]

Original Primary Outcome: Same as current

Current Secondary Outcome: The Secondary Outcome Measure in this trial will be efficacy for Sore Throat Pain during the first 2 hours. [ Time Frame: 2 hours ]

Original Secondary Outcome: Same as current

Information By: Reckitt Benckiser LLC

Dates:
Date Received: January 13, 2010
Date Started: November 2009
Date Completion:
Last Updated: April 1, 2011
Last Verified: April 2011